Agilent Technologies acquires Biocare Medical

Agilent Technologies agreed to acquire Biocare Medical. Reported deal value: $950M. Status: Announced. Sector: Clinical Pathology. Target headquarters context: Pacheco, California, United States.

This page summarizes publicly available information about the transaction as of 2026-03-09. Figures and status may change as filings and press coverage update.

News & Press Agilent to Acquire Biocare Medical , a Global Leader in Clinical and Research Pathology Solutions Expands Agilent pathology portfolio through addition of highly complementary antibody, reagent and instrument business with annual double-digit revenue and profit growth since 2021 Expected to be accretive to Agilent top-line growth rate, margin profile and non-instrument revenue mix in Year 1 SANTA CLARA , California and SAN FRANCISCO, California , March 9, 2026 – Agilent Technologies Inc. today announced it has entered into a definitive agreement to acquire Biocare Medical , a gl...